摘要
潜在的瘢痕疙瘩发病的分子机制尚不清楚。microRNA(miRNA)是一类小型的调控RNA,已涌现出一批如转录后基因抑制因子,参与皮肤病的多种病理生理学过程。我们研究了患者血清中miRNA的表达谱去破译参与瘢痕疙瘩疾病发展的复杂因素。使用包含了人类的成熟和前体miRNA序列的miRNA芯片去表征miRNA表达谱在9例瘢痕疙瘩患者和7例正常对照组的血清中。实时定量PCR验证miRNA的表达。差异表达的miRNA的假定目标通过生物信息学进行了功能注释。miRNA芯片鉴定了37个差异表达的miRNA(17上调和20下调)在瘢痕疙瘩患者中,同健康对照相比。功能注释表明,这些差异表达的miRNA的目标在信号通路上富集,是疤痕形成和伤口愈合的必不可少的原因。miRNA的表达谱在瘢痕疙瘩患者中被改变,这为其的起始和进展的分子机制提供线索。miRNA可能部分通过影响相关的瘢痕疙瘩发病机制中的关键信号通路而导致瘢痕疙瘩。
关键词: 瘢痕疙瘩;微小核糖核酸;血清;发病病因;疤痕;病因。
Current Molecular Medicine
Title:Serum miRNAs Signature Plays an Important Role in Keloid Disease
Volume: 16 Issue: 5
Author(s): Y. Luan, Y. Liu, C. Liu, Q. Lin, F. He, X. Dong, Z. Xiao
Affiliation:
关键词: 瘢痕疙瘩;微小核糖核酸;血清;发病病因;疤痕;病因。
摘要: The molecular mechanism underlying the pathogenesis of keloid is largely unknown. MicroRNA (miRNA) is a class of small regulatory RNA that has emerged as a group of posttranscriptional gene repressors, participating in diverse pathophysiological processes of skin diseases. We investigated the expression profiles of miRNAs in the sera of patients to decipher the complicated factors involved in the development of keloid disease. MiRNA expression profiling in the sera from 9 keloid patients and 7 normal controls were characterized using a miRNA microarray containing established human mature and precursor miRNA sequences. Quantitative real-time PCR was performed to confirm the expression of miRNAs. The putative targets of differentially expressed miRNAs were functionally annotated by bioinformatics. MiRNA microarray analysis identified 37 differentially expressed miRNAs (17 upregulated and 20 downregulated) in keloid patients, compared to the healthy controls. Functional annotations revealed that the targets of those differentially expressed miRNAs were enriched in signaling pathways essential for scar formation and wound healing. The expression profiling of miRNAs is altered in the keloid, providing a clue for the molecular mechanisms underlying its initiation and progression. MiRNAs may partly contribute to the etiology of keloids by affecting the critical signaling pathways relevant to keloid pathogenesis.
Export Options
About this article
Cite this article as:
Y. Luan, Y. Liu, C. Liu, Q. Lin, F. He, X. Dong, Z. Xiao , Serum miRNAs Signature Plays an Important Role in Keloid Disease, Current Molecular Medicine 2016; 16 (5) . https://dx.doi.org/10.2174/1566524016666160429121345
DOI https://dx.doi.org/10.2174/1566524016666160429121345 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cytokine Antibody Arrays in Biomarker Discovery and Validation
Current Proteomics Mechanisms and Therapeutic Targets of microRNA-associated Chemoresistance in Epithelial Ovarian Cancer
Current Cancer Drug Targets Polymer-Based Gene Delivery: A Current Review on the Uptake and Intracellular Trafficking of Polyplexes
Current Gene Therapy Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection
Current Drug Targets Recent Advances of Kinesin Motor Inhibitors and their Clinical Progress
Reviews on Recent Clinical Trials Theranostic Radiopharmaceuticals Targeting Cancer-Associated Fibroblasts
Current Radiopharmaceuticals Role of Vitamins in Human Health and Nutrition: Sources and Morbidity
Current Nutrition & Food Science The Effect of A Hexanoic Acid Linker Insertion on the Pharmacokinetics and Tumor Targeting Properties of the Melanoma Imaging Agent 99mTc-HYNIC-cycMSH
Anti-Cancer Agents in Medicinal Chemistry Animal Mitochondria: Evolution, Function, and Disease
Current Molecular Medicine NK Cell Receptor and MHC Gene Polymorphisms, Potential Relevance in Malignancies
Current Cancer Therapy Reviews Prospects for Anti-Neoplastic Therapies Based on Telomere Biology
Current Cancer Drug Targets Multidetector Computed Tomography of Iatrogenic Urinary Trauma - Pictorial Review
Current Medical Imaging Renal & Ocular Targets for Therapy in Wegeners Granulomatosis
Inflammation & Allergy - Drug Targets (Discontinued) Process Variables and Design of Experiments in Liposome and Nanoliposome Research
Mini-Reviews in Medicinal Chemistry Thermodynamics and Electro-Biologic Prospects for Therapies to Intervene in Cancer Progression
Current Cancer Therapy Reviews Contemporary Review of Drugs Used to Treat Obesity
Cardiovascular & Hematological Agents in Medicinal Chemistry 4'-Thionucleosides as Potent and Selective A<sub>3</sub> Adenosine Receptor Ligands
Current Organic Chemistry The Potential of Ellagic Acid as a Possible Antimalarial Drug Candidate
Current Bioactive Compounds Transmembrane Phosphatases and Cancer Development, the Role of Protein Tyrosine Phosphatase-kappa (PTPκ) and Protein Tyrosine Phosphatase-mu (PTPμ)
Current Signal Transduction Therapy New Insights Toward Nanostructured Drug Delivery of Plant-Derived Polyphenol Compounds: Cancer Treatment and Gene Expression Profiles
Current Cancer Drug Targets